Compounds > 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid
Page last updated: 2024-08-26

3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid and scopolamine hydrobromide

3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid has been researched along with scopolamine hydrobromide in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ballard, TM; Mcallister, KH1

Other Studies

1 other study(ies) available for 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid and scopolamine hydrobromide

ArticleYear
The NMDA antagonist EAA 494 does not impair working memory in an operant DNMTP task in rats.
    Pharmacology, biochemistry, and behavior, 2000, Volume: 65, Issue:4

    Topics: Animals; Conditioning, Operant; Excitatory Amino Acid Antagonists; Male; Memory, Short-Term; Motor Activity; Muscarinic Antagonists; Piperazines; Rats; Receptors, N-Methyl-D-Aspartate; Reward; Scopolamine

2000